Download
fimmu-12-693972.pdf 3,15MB
WeightNameValue
1000 Titel
  • Development of PDA Nanoparticles for H9N2 Avian Influenza BPP-V/BP-IV Epitope Peptide Vaccines: Immunogenicity and Delivery Efficiency Improvement
1000 Autor/in
  1. Liu, Yongqing |
  2. Wang, Xiaoli |
  3. Zhou, Jiangfei |
  4. Shi, Shuaibing |
  5. Shen, Tengfei |
  6. Chen, Liangliang |
  7. Zhang, Min |
  8. Liao, Chengshui |
  9. Wang, Chen |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-27
1000 Erschienen in
1000 Quellenangabe
  • 12:693972
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-29
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fimmu.2021.693972 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353371/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>The protection of current influenza vaccines is limited due to the viral antigenic shifts and antigenic drifts. The universal influenza vaccine is a new hotspot in vaccine research that aims to overcome these problems. Polydopamine (PDA), a versatile biomaterial, has the advantages of an excellent biocompatibility, controllable particle size, and distinctive drug loading approach in drug delivery systems. To enhance the immunogenicities and delivery efficiencies of H9N2 avian influenza virus (AIV) epitope peptide vaccines, PDA nanoparticles conjugated with the BPP-V and BP-IV epitope peptides were used to prepare the nano BPP-V and BP-IV epitope peptide vaccines, respectively. The characteristics of the newly developed epitope peptide vaccines were then evaluated, revealing particle sizes ranging from approximately 240 to 290 nm (PDI&amp;lt;0.3), indicating that the synthesized nanoparticles were stable. Simultaneously, the immunoprotective effects of nano BPP-V and BP-IV epitope peptide vaccines were assessed. The nano BPP-V and BP-IV epitope vaccines, especially nano BP-IV epitope vaccine, quickly induced anti-hemagglutinin (HA) antibody production and a sustained immune response, significantly promoted humoral and cellular immune responses, reduced viral lung damage and provided effective protection against AIV viral infection. Together, these results reveal that PDA, as a delivery carrier, can improve the immunogenicities and delivery efficiencies of H9N2 AIV nano epitope vaccines, thereby providing a theoretical basis for the design and development of PDA as a carrier of new universal influenza vaccines.</jats:p>
1000 Sacherschließung
lokal Lung/pathology [MeSH]
lokal NIH 3T3 Cells [MeSH]
lokal Vaccines, Subunit/immunology [MeSH]
lokal Vaccines, Subunit/chemistry [MeSH]
lokal Influenza Vaccines/chemistry [MeSH]
lokal Cytokines/metabolism [MeSH]
lokal Influenza Vaccines/administration
lokal Oligopeptides/chemistry [MeSH]
lokal Orthomyxoviridae Infections/pathology [MeSH]
lokal Lymphocyte Activation/drug effects [MeSH]
lokal Drug Carriers [MeSH]
lokal Epitopes [MeSH]
lokal polydopamine
lokal Orthomyxoviridae Infections/prevention
lokal Polymers/chemistry [MeSH]
lokal Immunity, Humoral/drug effects [MeSH]
lokal Orthomyxoviridae Infections/immunology [MeSH]
lokal Disease Models, Animal [MeSH]
lokal Nanoparticles [MeSH]
lokal Antibodies, Viral/blood [MeSH]
lokal Vaccines, Subunit/administration
lokal Immunology
lokal nano BP-IV epitope vaccine
lokal Lung/immunology [MeSH]
lokal Influenza A Virus, H9N2 Subtype/immunology [MeSH]
lokal Immunogenicity, Vaccine [MeSH]
lokal Animals [MeSH]
lokal Lung/drug effects [MeSH]
lokal H9N2 avian influenza virus
lokal Mice [MeSH]
lokal Indoles/chemistry [MeSH]
lokal Influenza Vaccines/immunology [MeSH]
lokal Oligopeptides/immunology [MeSH]
lokal Immunity, Cellular/drug effects [MeSH]
lokal Oligopeptides/administration
lokal Lung/virology [MeSH]
lokal nanoconjugates
lokal Drug Compounding [MeSH]
lokal Orthomyxoviridae Infections/virology [MeSH]
lokal Vaccination [MeSH]
lokal nano BPP-V epitope vaccine
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TGl1LCBZb25ncWluZw==|https://frl.publisso.de/adhoc/uri/V2FuZywgWGlhb2xp|https://frl.publisso.de/adhoc/uri/WmhvdSwgSmlhbmdmZWk=|https://frl.publisso.de/adhoc/uri/U2hpLCBTaHVhaWJpbmc=|https://frl.publisso.de/adhoc/uri/U2hlbiwgVGVuZ2ZlaQ==|https://frl.publisso.de/adhoc/uri/Q2hlbiwgTGlhbmdsaWFuZw==|https://frl.publisso.de/adhoc/uri/WmhhbmcsIE1pbg==|https://frl.publisso.de/adhoc/uri/TGlhbywgQ2hlbmdzaHVp|https://frl.publisso.de/adhoc/uri/V2FuZywgQ2hlbg==
1000 Hinweis
  • DeepGreen-ID: 5a1fc28b750641119d58c1bf546ec460 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6479956.rdf
1000 Erstellt am 2024-05-22T01:26:18.944+0200
1000 Erstellt von 322
1000 beschreibt frl:6479956
1000 Zuletzt bearbeitet 2024-05-22T15:07:12.495+0200
1000 Objekt bearb. Wed May 22 15:07:12 CEST 2024
1000 Vgl. frl:6479956
1000 Oai Id
  1. oai:frl.publisso.de:frl:6479956 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source